HAE Clinical Trials

240 recruitingLast updated: July 25, 2026

There are 240 actively recruiting hae clinical trials across 67 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 1, Phase 4, Early Phase 1. Top locations include London, United Kingdom, Southampton, United Kingdom, Cardiff, United Kingdom. Updated daily from ClinicalTrials.gov.


HAE Trials at a Glance

240 actively recruiting trials for hae are listed on ClinicalTrialsFinder across 6 cities in 67 countries. The largest study group is Not Applicable with 46 trials, with the heaviest enrollment activity in London, Southampton, and Cardiff. Lead sponsors running hae studies include Cancer Research UK, Novo Nordisk A/S, and Royal Brisbane and Women's Hospital.

Treatments under study

About HAE Clinical Trials

Looking for clinical trials for HAE? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HAE trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HAE clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 240 trials

Recruiting
Not Applicable

Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS

HAEHemorrhoids, InternalHemorrhoidal Bleeding+1 more
Jessica K. Stewart, MD40 enrolled1 locationNCT07559630
Recruiting
Phase 3

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

Acute intracerebral haemorrhageAcute StrokeIntracerebral Hemorrhage+2 more
The George Institute2,000 enrolled2 locationsNCT06763055
Recruiting

Transducer Levelling Errors in Everyday ICU Practice - A Multicentre Blinded Observational Study

Critically Illhaemodynamic instability
Vastra Gotaland Region60 enrolled2 locationsNCT07330505
Recruiting

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

Intraventricular hemorrhageSubarachnoid HemorrhageIntracerebral Hemorrhage+2 more
University of Maryland, Baltimore5,000 enrolled1 locationNCT04189471
Recruiting
Phase 3

Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis

Ischaemic Stroke
Beijing Tiantan Hospital934 enrolled3 locationsNCT07526987
Recruiting

Descriptive Study on MRI Contrast of Acute Cerebral Hemorrhage in Different Microangiopathies

Cerebral HemorrhageAcute Lobar Haematoma
Centre Hospitalier Universitaire de Nīmes128 enrolled1 locationNCT06781034
Recruiting
Phase 2Phase 3

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

Haematological MalignancySolid Tumour
Cancer Research UK825 enrolled27 locationsNCT05722886
Recruiting
Phase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Haemophilia A (Moderate or Severe)
Swedish Orphan Biovitrum104 enrolled21 locationsNCT06716814
Recruiting
Phase 3

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

Haemophilia AHaemophilia A With Inhibitors
Novo Nordisk A/S451 enrolled152 locationsNCT05685238
Recruiting
Not Applicable

Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds

Coronary Artery Disease (CAD)Angina, Stableischaemic heart disease (IHD)
Imperial College London60 enrolled7 locationsNCT07386418
Recruiting
Phase 3

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])

Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis
TJ Biopharma Co., Ltd.30 enrolled15 locationsNCT07208058
Recruiting
Phase 4

NICardipine for Fast Achievement of Systolic BP Targets in ICH

Intracerebral haemorrhage
Aarhus University Hospital88 enrolled1 locationNCT07044232
Recruiting
Phase 1Phase 2

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Acute Myeloid LeukemiaNon-Hodgkin LymphomaMultiple Myeloma+3 more
CellCentric Ltd.250 enrolled39 locationsNCT04068597
Recruiting
Phase 3

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage

Traumatic Intracranial Haemorrhage
Walton Centre NHS Foundation Trust1,084 enrolled2 locationsNCT06322953
Recruiting

A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

Hereditary Angioedema (HAE)
Takeda40 enrolled24 locationsNCT07251933
Recruiting
Phase 2

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

Essential Thrombocythaemia
Step Pharma, SAS50 enrolled14 locationsNCT06786234
Recruiting
Phase 3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary AngioedemaHereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled51 locationsNCT06960213
Recruiting
Not Applicable

Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)

Solid CancerHaematological Malignancies
Institut Claudius Regaud33 enrolled1 locationNCT06797037
Recruiting
Phase 3

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)Hereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled48 locationsNCT07428499
Recruiting
Phase 4

A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India

Severe Postpartum Haemorrhage
Novo Nordisk A/S64 enrolled10 locationsNCT07157423